These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25733953)

  • 21. Personalized Medicine: Review and Perspectives of Promising Baseline EEG Biomarkers in Major Depressive Disorder and Attention Deficit Hyperactivity Disorder.
    Olbrich S; van Dinteren R; Arns M
    Neuropsychobiology; 2015; 72(3-4):229-40. PubMed ID: 26901357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance imaging and prediction of outcome in patients with major depressive disorder.
    MacQueen GM
    J Psychiatry Neurosci; 2009 Sep; 34(5):343-9. PubMed ID: 19721844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychoradiological Biomarkers for Psychopharmaceutical Effects.
    Schrantee A; Ruhé HG; Reneman L
    Neuroimaging Clin N Am; 2020 Feb; 30(1):53-63. PubMed ID: 31759572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. State-Dependent Differences in Emotion Regulation Between Unmedicated Bipolar Disorder and Major Depressive Disorder.
    Rive MM; Mocking RJ; Koeter MW; van Wingen G; de Wit SJ; van den Heuvel OA; Veltman DJ; Ruhé HG; Schene AH
    JAMA Psychiatry; 2015 Jul; 72(7):687-96. PubMed ID: 25945779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward the application of functional neuroimaging to individualized treatment for anxiety and depression.
    Ball TM; Stein MB; Paulus MP
    Depress Anxiety; 2014 Nov; 31(11):920-33. PubMed ID: 25407582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging antidepressants to treat major depressive disorder.
    Block SG; Nemeroff CB
    Asian J Psychiatr; 2014 Dec; 12():7-16. PubMed ID: 25277330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A meta-analysis of neurofunctional imaging studies of emotion and cognition in major depression.
    Diener C; Kuehner C; Brusniak W; Ubl B; Wessa M; Flor H
    Neuroimage; 2012 Jul; 61(3):677-85. PubMed ID: 22521254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain correlates of antidepressant treatment outcome from neuroimaging studies in depression.
    Dougherty DD; Rauch SL
    Psychiatr Clin North Am; 2007 Mar; 30(1):91-103. PubMed ID: 17362806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neuronal effects and biomarkers of antidepressant treatments : Current review from the perspective of neuroimaging].
    Enneking V; Dzvonyar F; Dannlowski U; Redlich R
    Nervenarzt; 2019 Mar; 90(3):319-329. PubMed ID: 30729991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of thalamic hyperactivity with treatment-resistant depression and poor response in early treatment for major depression: a resting-state fMRI study using fractional amplitude of low-frequency fluctuations.
    Yamamura T; Okamoto Y; Okada G; Takaishi Y; Takamura M; Mantani A; Kurata A; Otagaki Y; Yamashita H; Yamawaki S
    Transl Psychiatry; 2016 Mar; 6(3):e754. PubMed ID: 26954981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional homogeneity in depression and its relationship with separate depressive symptom clusters: a resting-state fMRI study.
    Yao Z; Wang L; Lu Q; Liu H; Teng G
    J Affect Disord; 2009 Jun; 115(3):430-8. PubMed ID: 19007997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination psychotherapy and antidepressant medication treatment for depression: for whom, when, and how.
    Craighead WE; Dunlop BW
    Annu Rev Psychol; 2014; 65():267-300. PubMed ID: 24405361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional neuroimaging studies of bipolar disorder: examining the wide clinical spectrum in the search for disease endophenotypes.
    Pan L; Keener MT; Hassel S; Phillips ML
    Int Rev Psychiatry; 2009; 21(4):368-79. PubMed ID: 20374150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic Resonance Imaging Measures of Brain Structure to Predict Antidepressant Treatment Outcome in Major Depressive Disorder.
    Korgaonkar MS; Rekshan W; Gordon E; Rush AJ; Williams LM; Blasey C; Grieve SM
    EBioMedicine; 2015 Jan; 2(1):37-45. PubMed ID: 26137532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary Findings Supporting Insula Metabolic Activity as a Predictor of Outcome to Psychotherapy and Medication Treatments for Depression.
    Dunlop BW; Kelley ME; McGrath CL; Craighead WE; Mayberg HS
    J Neuropsychiatry Clin Neurosci; 2015; 27(3):237-9. PubMed ID: 26067435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of individual response to antidepressants and antipsychotics: an integrated concept.
    Preskorn SH
    Dialogues Clin Neurosci; 2014 Dec; 16(4):545-54. PubMed ID: 25733958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personalized medicine in Alzheimer's disease and depression.
    Souslova T; Marple TC; Spiekerman AM; Mohammad AA
    Contemp Clin Trials; 2013 Nov; 36(2):616-23. PubMed ID: 23816492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of mind on brain activity: evidence from neuroimaging studies of psychotherapy and placebo effect.
    Beauregard M
    Nord J Psychiatry; 2009; 63(1):5-16. PubMed ID: 19023697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychotherapy and pharmacotherapy in depression.
    Powers RH; Kniesner TJ; Croghan TW
    J Ment Health Policy Econ; 2002 Dec; 5(4):153-61. PubMed ID: 14578549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging treatment effects in depression.
    Höflich A; Baldinger P; Savli M; Lanzenberger R; Kasper S
    Rev Neurosci; 2012; 23(3):227-52. PubMed ID: 22752781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.